Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.10.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 14, 2018
Document And Entity Information    
Entity Registrant Name Boston Therapeutics, Inc.  
Entity Central Index Key 0001473579  
Document Type 10-Q  
Trading Symbol BTHE  
Document Period End Date Sep. 30, 2018  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity's Reporting Status Current Yes  
Entity Small Business true  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company false  
Elected Not To Use the Extended Transition Period false  
Entity Common Stock, Shares Outstanding   110,131,373
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2018